CMG
Chipotle Mexican Grill, Inc.
CMG has the edge over F overall, supported by stronger valuation and stronger fundamentals.
F
Ford Motor Company
F's outlook is improving, though it still trails on the overall score.
CMG Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Healthy | |
| Strong |
CMG's revenue, profitability, cash flow and balance sheet are all currently healthy.
F Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Under pressure | |
| Strong |
F's balance sheet is currently strong, and its revenue is stable, but its profitability and cash flow are under pressure.
CMG PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 28x | $35.17 | — |
| Current | 33x | $35.17 | — |
| Cheap | 37x | $39.28 | +12% |
| Fair | 56x | $59.81 | +70% |
| Expensive | 91x | $97.34 | +177% |
Historical ranges are pointers, not guarantees.
CMG's PE is in its cheap range at 33x. If earnings grow as analysts expect, today's price would be 28x next year's earnings.
F PE Valuation
F has no meaningful PE right now: it lost money over the past year.
CMG Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Moderate | |
| Low |
CMG has the edge over F on the outlook, with more favorable revenue expectations.
F Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Stable | |
| Improving | |
| Limited | |
| Low |
Analysts expect F's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
CMG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.27 | +19% |
| Q3 2026 | $1.07 | -5.3% |
| Q2 2026 | $1.09 | -2.7% |
| Q1 2026 | $1.09 | -3.5% |
| Q4 2025 | $1.14 | +2.7% |
| Q3 2025 | $1.13 | +5.6% |
| Q2 2025 | $1.12 | +9.8% |
| Q1 2025 | $1.13 | +20% |
| Q4 2024 | $1.11 | +25% |
CMG has the edge over F on earnings quality, reporting a profit while its opponent remains loss making.
F Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.78 | — |
| Q3 2026 | -$1.97 | -270% |
| Q2 2026 | -$1.87 | -340% |
| Q1 2026 | -$1.55 | -224% |
| Q4 2025 | -$2.06 | -241% |
| Q3 2025 | $1.16 | +32% |
| Q2 2025 | $0.78 | -19% |
| Q1 2025 | $1.25 | +29% |
| Q4 2024 | $1.46 | +35% |
F has swung to a loss: it lost $1.97 per share over the past year, after a profit the year before.
CMG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $3.3B | +9.6% |
| Q2 2026 | $3.3B | +9.3% |
| Q1 2026 | $3.1B | +7.4% |
| Q4 2025 | $3B | +4.9% |
| Q3 2025 | $3B | +7.5% |
| Q2 2025 | $3.1B | +3% |
| Q1 2025 | $2.9B | +6.4% |
| Q4 2024 | $2.8B | +13% |
CMG has the edge over F on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | -2.2 points |
| Q2 2026 | 16% | -2.6 points |
| Q1 2026 | 13% | -3.8 points |
| Q4 2025 | 14% | -0.5 points |
| Q3 2025 | 16% | -1.1 points |
| Q2 2025 | 18% | -1.5 points |
| Q1 2025 | 17% | +0.3 points |
| Q4 2024 | 15% | +0.2 points |
CMG has the edge over F on profitability, with a higher operating margin.
F Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $49.5B | -2% |
| Q2 2026 | $48.3B | -3.8% |
| Q1 2026 | $43.3B | +6.4% |
| Q4 2025 | $45.9B | -4.8% |
| Q3 2025 | $50.5B | +9.4% |
| Q2 2025 | $50.2B | +5% |
| Q1 2025 | $40.7B | -5% |
| Q4 2024 | $48.2B | +4.9% |
F's revenue grew through 2023 and has held roughly level since: $49.5B last quarter, down 2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.9% | -0.1 points |
| Q2 2026 | 1.3% | +0.3 points |
| Q1 2026 | 5.4% | +4.6 points |
| Q4 2025 | -25% | -28 points |
| Q3 2025 | 3.1% | +1.2 points |
| Q2 2025 | 1% | -2.9 points |
| Q1 2025 | 0.8% | -2.1 points |
| Q4 2024 | 2.5% | +3.1 points |
F's operating margin was 2.9% last quarter, about level with the same quarter a year ago.
CMG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $347.1M | -15% |
| Q2 2026 | $463.4M | +16% |
| Q1 2026 | $471M | +14% |
| Q4 2025 | $228.4M | -35% |
| Q3 2025 | $406.2M | +36% |
| Q2 2025 | $400.7M | -5.1% |
| Q1 2025 | $412.3M | -5.6% |
| Q4 2024 | $353.9M | +278% |
CMG generated $1.5B in free cash flow over the past year, down 4% from the year before.
F Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.1B | -40% |
| Q2 2026 | $2B | -54% |
| Q1 2026 | -$1.1B | -157% |
| Q4 2025 | $1.1B | +108% |
| Q3 2025 | $5.3B | +50% |
| Q2 2025 | $4.2B | +24% |
| Q1 2025 | $1.9B | +$2.6B |
| Q4 2024 | $530M | +169% |
F has the edge over CMG on cash flow, with more consistent year-over-year improvement.
CMG Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.9% | -11.4M shares |
| 1 year | -5.4% | -71.8M shares |
| 3 years | -8.4% | -116M shares |
| 5 years | -11% | -156M shares |
| Available history | -10% | -147M shares |
CMG has the edge over F on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $110M |
| Q2 2026 | $653.9M |
| Q1 2026 | $701M |
| Q4 2025 | $741.8M |
| Q3 2025 | $686.7M |
| Q2 2025 | $443.3M |
| Q1 2025 | $553.8M |
| Q4 2024 | $339M |
CMG spent $2.2B buying back its own shares over the past year, up 9.1% from the year before.
F Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +2.2% | +89M shares |
| 1 year | +0.7% | +28M shares |
| 3 years | +0.6% | +26M shares |
| 5 years | +1% | +40M shares |
| Available history | +1.8% | +72M shares |
F has 4.1B diluted shares, up 0.7% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $311M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $150M |
F spent $311M buying back its own shares over the past year, up 107% from the year before.
CMG Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.3x | Net Cash |
| Q2 2026 | -0.1x | Net Cash |
| Q1 2026 | -0.1x | Net Cash |
| Q4 2025 | -0.2x | Net Cash |
| Q3 2025 | -0.3x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | -0.3x | Net Cash |
CMG has more cash than debt.
F Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -2.5x | Net Cash |
| Q2 2026 | -2.1x | Net Cash |
| Q1 2026 | -2.0x | Net Cash |
| Q4 2025 | -3.4x | Net Cash |
| Q3 2025 | -2.4x | Net Cash |
| Q2 2025 | -2.2x | Net Cash |
| Q1 2025 | -1.8x | Net Cash |
| Q4 2024 | -1.8x | Net Cash |
F has the edge over CMG on leverage, with a lower net debt burden relative to earnings.
CMG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.1 | Neutral |
| Stochastic | 56.0 | Neutral |
CMG's weekly RSI is 53 (neutral) and its Stochastic is 56 (neutral).
F Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.5 | Neutral |
| Stochastic | 19.6 | Oversold |
F's weekly RSI is 41 (neutral) and its Stochastic is 20 (oversold).
CMG PE vs Consumer Cyclical Sector
| Metric | CMG | Sector median | Relative |
|---|---|---|---|
| PE | 33x | 18x | 82% above |
| PE % | 11 | 47 | 36 pts below |
CMG is trading at 33x earnings, a 82% premium to the Consumer Cyclical sector's median of 18x.
F PE vs Consumer Cyclical Sector
| Metric | F | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
F has no meaningful PE right now: it lost money over the past year.
CMG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $31.8 | 11% above |
| 20 week MA | $33.8 | 4.1% above |
| 50 week MA | $34.6 | 1.7% above |
| 100 week MA | $41.3 | 15% below |
| 200 week MA | $44.6 | 21% below |
CMG has the edge over F on trend strength, trading above more of its moving averages.
F Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $12.2 | 2.5% below |
| 20 week MA | $13.3 | 11% below |
| 50 week MA | $13.4 | 11% below |
| 100 week MA | $12.1 | 2% below |
| 200 week MA | $12.1 | 1.4% below |
F is in a downtrend: it's below all five of its weekly moving averages, and 1.4% below its 200-week average.
CMG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $16.7 | $28.3 | +69% |
| 2021 | $28.3 | $35.0 | +24% |
| 2022 | $35.0 | $28.3 | -19% |
| 2023 | $28.3 | $45.7 | +62% |
| 2024 | $45.7 | $60.8 | +33% |
| 2025 | $60.8 | $37.8 | -38% |
| 2026 YTD | $37.8 | $35.2 | -7% |
CMG has the edge over F on returns for 2026, with the stronger performance.
F Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.36 | $8.86 | -5.3% |
| 2021 | $8.86 | $20.3 | +129% |
| 2022 | $20.3 | $11.4 | -44% |
| 2023 | $11.4 | $12.2 | +7.3% |
| 2024 | $12.2 | $10.0 | -18% |
| 2025 | $10.0 | $13.3 | +33% |
| 2026 YTD | $13.3 | $11.9 | -11% |
F's yearly returns have swung widely, from +129% in 2021 to −44% in 2022. It's down 11% so far in 2026.